FOSTER L B CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FOSTER L B CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	484	536	581	616	497	514	497	544	531	540
Cost of revenue	393	431	468	495	402	427	408	432	413	426
Gross profit	90.4	105	113	121	95	86.3	89.6	112	118	114
Research and development	3.51	2.24	2.65	2.61	2.64	2.23	2.22	2.56	2.83	3.64
Selling, general and administrative	86	80.5	82.7	82.5	73.6	76	82.7	97.6	96.4	88.6
Operating income	-134	28.6	38.9	36.5	15.6	4.47	-7.21	9.11	20.5	21.9
Interest expense	6.55	8.07	6.13	4.91	3.76	2.96	3.34	5.53
Interest income	0.23	0.31
Other non-operating income	1.52	0.37	1.21	-2.92	2.11	3.08	1.55	-2.64	-1.08	0.42
Pre-tax income	-147	10.1	-24.6	24.1	14	4.59	-9	0.94	14.4	17.4
Income tax	-5.51	4.69	6.02	-23.8	-11.8	1.12	36.7	-0.36	-28.4	10
Income from continuing operations					25.8	3.55	-45.6
Net income to minority interests					0	-0.08	-0.11	-0.17	-0.1	-0.13
Net income	-142	5.36	-31.2	42.6	7.58	3.63	-45.6	1.46	42.9	7.55
EBITDA	-120	48.4	53.9	50.9	29.2	18.4	7.57	24.4	34.6	34.3
EPS, basic	-14.39	0.52	-3.01	4.09	0.72	0.34	-4.25	0.14	4.01	0.73
EPS, diluted	-14.39	0.51	-3.01	4.00	0.71	0.34	-4.25	0.13	3.89	0.69
Shares, basic (weighted)	9.84	10.3	10.4	10.4	10.5	10.6	10.7	10.8	10.7	10.4
Shares, diluted (weighted)	9.84	10.5	10.4	10.6	10.7	10.8	10.7	11	11	10.9
Dividend per share	0.13	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	30.4	37.7	10.3	14.2	7.56	10.4	2.88	2.56	2.45	4.35
Receivables	63.3	72.4	82.3	73.5	58.2	55.9	82.5	53.5	65	80.6
Inventory	83.2	103	125	118	78.6	62.9	75.7	73.1	70.5	60.2
Other current assets	5.2	9.12	5.76	4.1	13	14.1	11.1	8.71	6.95	5.36
Total current assets	200	226	227	217	195	179	206	167	162	157
Property, plant and equipment	104	96.1	86.9	82.3	62.1	58.2	85.3	75.6	75.4	77.2
Lease right-of-use assets				11.3	16.1	15.1	17.3	14.9	18.5	28.3
Goodwill	18.9	19.8	19.3	19.6	20.3	20.2	30.7	32.6	31.9	33.1
Intangible assets	63.5	57.4	49.8	42.1	36.9	31	23.8	19	14.8	11.5
Other non-current assets	2.96	2.12	0.63	1.12	1.2	1.35	2.38	2.97	3.48	3.07
Total assets	393	402	383	405	370	343	365	312	335	330
Accounts payable	37.7	52.4	78.3	63	54.8	41.4	48.8	39.5	50.1	52.5
Accrued liabilities	8.95	9.76	13.6	15.6	15.7	13.8	16.2	17.4	12.4	14
Deferred revenue	7.6	1.42	6.62	8.45	7.14	13.4	19.5	12.5	10.2	5.9
Short-term debt	10.4	0.66	0.63	2.88	0.12	0.1	0.13	0.1	0.17	0.15
Total current liabilities	82.3	93.5	124	117	95.3	86.2	103	94.5	88.3	83.9
Long-term debt	149	129	74.4	55.3	44.9	31.2	91.8	55.2	46.8	42.6
Lease liabilities			0	9.01	13.5	12.3	14.2	11.9	14.7	24.3
Other non-current liabilities	16.9	17.5	17.3	11.9	11.8	9.61	7.58	6.8	4.61	2.68
Total liabilities	260	247	261	235	194	159	228	170	156	154
Total debt	160	130	75	58.2	45	31.3	91.9	55.3	46.9	42.8
Paid-in capital	44.1	45	48	49.2	44.6	43.3	41.3	43.1	43.6	44.8
Retained earnings	134	146	114	158	165	169	123	125	168	175
Treasury stock	-19.3	-18.7	-18.2	-16.8	-12.7	-10.2	-6.24	-6.49	-11.2	-23.9
Other comprehensive income	-25.3	-17.8	-22.2	-20.2	-20.3	-18.8	-21.2	-19.3	-21.7	-20.9
Shareholders' equity	133	154	122	170	177	183	137	142	178	175
Minority interests					0	0.52	0.42	0.72	0.7	0.72
Total equity	133	154	122	170	177	184	138	143	179	176
Total liabilities and equity	393	402	383	405	370	343	365	312	335	330
Shares outstanding	9.88	10.3	10.4	10.4	10.6	10.7	10.8	10.7	10.6	10.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-142	5.36	-31.2	42.6	7.58	3.54	-45.7	1.3	42.8	7.42
Depreciation and amortization	13.9	19.8	15	14.4	13.6	13.9	14.8	15.3	14.1	12.5
Stock-based compensation	1.35	1.7	3.84	3.16	1.14	1.95	2.38	4.18	3.83	5.06
Deferred income tax	3.38	-1.22	-1.6	-30.4	-4.32	0.14	35.8	-1.85	-29.1	8.37
Change in inventory	10.5	-14.7	-23.5	6.5	3.23	-3.97	-11.8	-6.6	2.38	9.58
Change in payables	-16	14.6	24.7	-13	-8.95	-13.6	10.1	-4.56	10.4	2.01
Cash from operations	18.4	39.4	26	29.3	20.5	-0.81	-10.6	37	22.6	35.6
Capital expenditures	-7.66	-6.15	-3.66	-6.03	-9.18	-4.62	-7.63	-4.51	-9.79	-10.4
Acquisitions	0	0	0	0	-1.16	-0.23	-57.9	-1.25	-0.42	0
Cash from investing	-7.93	-4.69	2.25	-7.68	-10.3	17.8	-56.4	2.49	-6.31	-10.4
Stock issued	0	0
Share buybacks	-0.34	-0.1	-0.32	-0.62	-1.67	-0.73	-0.41	-2.63	-8.24	-16.5
Dividends paid	-1.24	0
Cash from financing	-12.5	-29.7	-55.3	-18.2	-15.3	-13.9	60.2	-39.3	-16.2	-23.5
Exchange rate effect	-0.91	2.33	-0.31	0.53
Net change in cash	-2.95	7.32	-27.4	3.9	-6.61	2.81	-7.49	-0.32	-0.11	1.89
Free cash flow	10.7	33.2	22.3	23.3	11.4	-5.43	-18.2	32.4	12.8	25.2
Interest paid	4.86	7.59	5.58	4.59	3.27	2.62	2.7	5.45	4.66	4.92
Income taxes paid	3.94	-11.2	4.51	6.51	2.63	1.49	-5.01	-0.22	1.63	1.63

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $37.47 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	21.4%	Gross profit / revenue.
Operating margin	4.4%	Operating income / revenue.
EBITDA margin	6.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.7%	Pre-tax income / revenue.
Net margin	2.0%	Net income / revenue.
FCF margin	8.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.5%	Cash from operations / revenue.
Effective tax rate	45.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	6.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.4%	Net income / average total assets.
Return on invested capital (ROIC)	6.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	16.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.1%	Capital expenditures / revenue.
D&A / revenue	2.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	8.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y	7.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	65.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	3.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-82.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	-0.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-82.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	-0.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	57.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	11.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	96.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	17.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-1.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-0.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.00x	Current assets / current liabilities.
Quick ratio	1.01x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.07x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.27x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	14.4%	Total debt / total assets.
Liabilities / assets	46.5%	Total liabilities / total assets.
Net debt	$42.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.18x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$82.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	12.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$135.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.67x	Revenue / average total assets.
Fixed asset turnover	7.06x	Revenue / average property, plant and equipment.
Inventory turnover	6.31x	Cost of revenue / average inventory.
Days inventory	58 days	365 x average inventory / cost of revenue.
Receivables turnover	7.29x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	67 days	Days inventory + days sales outstanding - days payables.
FCF conversion	413.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	19.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.07	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$52.64	Revenue / diluted weighted shares.
FCF per share	$4.44	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.54	Cash from operations / diluted weighted shares.
Book value per share	$17.16	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$13.01	Tangible book value / shares outstanding.
Cash per share	$0.56	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	26.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$394.2M	Share price x shares outstanding.
Enterprise value	$436.4M	Market cap + total debt - cash - short-term investments.
P/E	34.6x	Market cap / net income. Only when net income is positive.
P/S	0.71x	Market cap / revenue.
P/B	2.21x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.92x	Market cap / tangible book value, when positive.
P/FCF	8.37x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.71x	Market cap / cash from operations, when positive.
EV/Sales	0.78x	Enterprise value / revenue.
EV/EBIT	17.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	9.27x	Enterprise value / free cash flow, when both are positive.
FCF yield	11.9%	Free cash flow / market cap.
Earnings yield	2.9%	Net income / market cap (the inverse of P/E).
Shareholder yield	3.1%	(Dividends paid + share buybacks) / market cap.

What was FOSTER L B CO's revenue in fiscal 2025?

FOSTER L B CO reported revenue of $540.0M for fiscal 2025, 1.7% higher than the year before.

Was FOSTER L B CO profitable in fiscal 2025?

Yes. Net income was $7.5M, a net margin of 1.4%.

How much free cash flow did FOSTER L B CO generate in fiscal 2025?

Cash from operations of $35.6M minus capital expenditures of $10.4M left free cash flow of $25.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FOSTER L B CO